Skip to content

Dilated Cardiomyopathy 1v C3150958

Published: July 22, 2026Updated: August 20, 2026

This genetic type of dilated cardiomyopathy involves progressive weakening of the heart muscle. Family screening may be recommended. Management includes standard heart failure drugs and lifestyle modifications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
B33.24
ICD-11
1A00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

!

Syncope

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dyspnea on exertion

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

SGLT2 Inhibitors

These newer diabetes medications have demonstrated significant benefits in heart failure patients regardless of diabetes status, reducing hospitalizations and improving outcomes through cardiorenal mechanisms.

medication
3

Smoking Cessation and Alcohol Abstinence

Complete cessation of tobacco and alcohol eliminates cardiotoxic exposures that worsen cardiac function and reduces overall cardiovascular risk.

lifestyle

Additional treatment options

Ivabradine

This heart-rate-lowering agent specifically targets the sinoatrial node and can be added when beta-blockers alone provide insufficient heart rate control or are contraindicated.

medication

Heart Transplantation Evaluation

For eligible patients with end-stage disease refractory to maximal medical therapy, comprehensive transplant evaluation determines candidacy for this life-saving intervention.

surgical

Coenzyme Q10 Supplementation

Some evidence suggests CoQ10 may improve cellular energy production in cardiac muscle and reduce symptoms, though it should not replace evidence-based medications.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dilated Cardiomyopathy 1v C3150958?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Dilated Cardiomyopathy 1v C3150958. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy